Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 227,043 | 251,455 | 477,706 | 313,837 | 76,657 |
| Cost of Goods | 44,548 | 54,005 | 204,216 | 129,690 | 15,611 |
| Gross Profit | 182,495 | 197,450 | 273,490 | 184,147 | 61,046 |
| Operating Expenses | 742,800 | 1,061,861 | 2,482,658 | 2,013,304 | 198,684 |
| Operating Income | -559,757 | -864,406 | -2,208,952 | -1,828,467 | -137,027 |
| Interest Expense | 94 | 93 | 106 | 2,373 | 2,385 |
| Other Income | 12,343 | -28,441 | 87,659 | -7,282 | 14,578 |
| Pre-tax Income | -547,508 | -892,940 | -2,121,399 | -1,838,122 | -124,834 |
| Income Tax | -479 | -71 | -15,027 | -1,480 | 1,889 |
| Net Income Continuous | -547,029 | -892,869 | -2,106,372 | -1,836,642 | -126,723 |
| Minority Interests | N/A | N/A | -1,443 | -6,595 | -114 |
| Net Income | $-547,029 | $-892,869 | $-2,104,929 | $-1,830,047 | $-126,609 |
| EPS Basic Total Ops | -10.54 | -18.37 | -50.15 | -54.00 | -4.00 |
| EPS Basic Continuous Ops | -10.54 | -18.37 | -50.18 | -54.02 | -3.98 |
| EPS Diluted Total Ops | -10.54 | -18.37 | -50.20 | -55.60 | -4.00 |
| EPS Diluted Continuous Ops | -10.54 | -18.37 | -50.16 | -54.00 | -3.98 |
| EPS Diluted Before Non-Recurring Items | -10.36 | -15.60 | -34.40 | -6.00 | N/A |
| EBITDA(a) | $-448,879 | $-793,899 | $-2,166,400 | $-1,799,391 | $-123,163 |